InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Helliwell, James Allen. Insider active across 1 company, notably Eupraxia Pharmaceuticals Inc.. Aggregated, 4 disclosures have been published. Activity tracked since 15 December 2025. The latest transaction was filed on 15 June 2026 (50 - Grant of options). Regulator: SEDI. All data is accessible without signup.
4 of 4 declarations
James Allen Helliwell is a declarant linked to Eupraxia Pharmaceuticals Inc., where he is listed as 4 - Director of Issuer. The 4 known filings, in the sampled filings from 2025-12-22 to 2026-06-18, concern 56 - Grant of rights transactions, with buy and sell volumes of 0 EUR.